← Eichor
Study identifier: NCT06907784 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

PRE-EMPTIVE PHARMACOGENOMICS IN ACUTE CARE SETTINGS WITH HEALTH ECONOMIC EVALUATIONS (PHOENIX TRIAL)

Condition: Pharmacogenomic Drug Interaction  ·  Sponsor: NHS Greater Glasgow and Clyde

PhaseNA
Planned participants2000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

It is known that individuals respond differently to the same medicine with some people benefitting, some experiencing no effect and others suffering side-effects or even coming to harm. Some of the differences in response to medications can be explained by our genes. Genes are short sections of DNA. Each individual has over 20,000 different genes. Genes carry instructions for making the proteins needed to build things within the body including the sites where medicines act. Pharmacogenomics is the study of how our genes affect the way our body responds to medications. Doctors can test for gene variations that might put an individual at risk of severe side-effects or mean that they are likely to receive no benefit from a specific medicine. Though not widely available in the NHS, testing allows doctors and patients to chose a different dose or avoid the medicine completely. It is estimated that almost everyone in the population (\>95%) carries at least one gene variation that affects our response to medicines. The PHOENIX study will recruit 4,000 participants who are admitted to hospital or attend an outpatient clinic who require a new drug prescription. The new drug prescription will be one who known pharmacogenomic implications. A cheek (buccal) swab will be taken which can be used to test a large number of genes known to alter the response to medicines. Around half of the participants will be tested immediately whilst the other half will have the test after three months. T…

This description comes directly from the study's public registry record.

Talk to the study team

Elaine O'Neill  ·  0141 451 6869  ·  elaine.oneill3@nhs.scot

Stefanie Lip, PhD MBChB BSc  ·  stefanie.lip@glasgow.ac.uk

Always discuss trial participation with your own doctor first.

Locations (5)

Golden Jubilee National HospitalClydebank, United KingdomRecruiting
Queen Elizabeth University HospitalGlasgow, United KingdomRecruiting
Glasgow Royal InfirmaryGlasgow, United KingdomRecruiting
Leverndale HospitalGlasgow, United KingdomRecruiting
Royal Alexandra HospitalGlasgow, United KingdomActive Not Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06907784